R eports have shown that research priorities for patients and caregivers are not reflected in research published in medical journals. [1] [2] [3] One approach to address this problem is engaging patients and caregivers in setting research priorities. There are 3 principal arguments for involving patients in setting research priorities. First of all, patients have experiential knowledge gained from living with an illness and are able to provide valuable insight on which research topics are most relevant for them. 4 Second, given that a large part of medical research is publicly funded, there is a democratic argument for involving patients in setting research priorities, because they are taxpayers. 4 Lastly, the patients are the direct beneficiaries of the research outcomes, and research should thus strive to meet their important needs. 4 Recently, various initiatives and institutes have focused on patient engagement in research, such as the Strategy for Patient-Oriented Research by the Canadian Institutes of Health Research, 5 the Patient Centered-Outcomes Research Institute 6 in the United States, and INVOLVE in the United Kingdom. 7 Patients have also recently been involved in setting research priorities for chronic kidney disease, 8, 9 rheumatology, 10 chronic obstructive pulmonary disease, 11 and breast cancer. 12 In the field of solid organ transplantation (SOT), several priority-setting exercises have been published in recent years. Tong and colleagues 13 published a systematic review reporting 28 studies with research priority setting in SOT. Among these studies, only 32% of them involved patients in the priority-setting process, and only in the fields of kidney and heart transplantation. In this systematic review, there is no report of a priority-setting activity involving patients, families, caregivers, researchers, and healthcare professionals (HCPs) in the combined fields of donation, SOT, and hematopoietic cell transplantation (HCT). In the fields of HCT and organ and tissue donation, there have been no reported prioritysetting activities involving patients and caregivers.
The Canadian National Transplant Research Program (CNTRP) is a national research initiative designed to increase organ and tissue donation in Canada, improve graft survival, and enhance the quality of life of Canadians living with a transplant. 14, 15 The program brings together over 150 funded and active researchers, patients, and trainees in the field of donation and SOT and HCT. The CNTRP aims to increase patient engagement in research and to support novel ways to integrate patients and families as active participants across the research network. For the CNTRP, patient engagement occurs when "patients meaningfully and actively collaborate in the governance, priority setting, and conduct of research, as well as in summarizing, distributing, sharing, and applying its resulting knowledge."
5 To achieve this goal of patient engagement across the CNTRP, the latter conducted a French-language pilot workshop with 10 patients and 5 researchers in August 2014, in Montréal. 2 The objective of the current study was to refine the preliminary research priorities identified during the pilot workshop, elicit new priorities from a broader national cohort of patients, and rank them by order of priority. This was achieved through the development and launch of a national priority-setting survey followed by a workshop with patients, caregivers, HCPs, and researchers to evaluate and rank the research priorities. The final list of research priorities will be used by the CNTRP to determine future research projects/studies.
MATERIALS AND METHODS
The survey and national-workshop participants were asked to use their experiences as patients, family members, caregivers, researchers, and/or HCPs to help identify the top research priorities in transplantation and donation within the CNTRP. The ethics review board of the Centre hospitalier de l'Université de Montréal approved the survey and the workshop, and all participants provided informed consent before answering the survey and participating in the workshop.
Survey
A bilingual (French and English) online survey was conducted with patients (SOT and HCT recipients, transplant candidates and living donors), caregivers, deceased donors' family members, transplant professionals, and researchers in Canada. Findings from the pilot workshop 2 were used as a guide to develop the survey questions. The team that developed the survey included several researchers in the fields of clinical transplantation, ethics, and social work, as well as 2 patients. The survey questions addressed challenges surrounding various aspects of transplantation, grouped into the following 6 themes: (i) pretransplant, (ii) posttransplant, (iii) biomedical, (iv) psychological and social, (v) ethical and legal, and (vi) healthcare organization-related (refer to SDC, Appendix 1 http://links.lww.com/TXD/A101for survey questions.) The team decided to group the questions into these 6 themes to elicit research priorities from every step of the patients' journey.
The survey included 9 multiple-choice questions, as well as 1 open-ended question allowing respondents to add research themes or priorities. These additional research themes or priorities were read and coded by 2 independent coders from the research group (F.B. and C.M.) and were reclassified into an existing theme where appropriate. To answer the multiplechoice questions, participants were asked to choose the top 3 issues that they felt should be addressed in research within each theme. At the end of the survey, the respondents ranked 14 research priorities from most to least important. This final list of 14 priorities included the 10 original priorities identified during the pilot workshop and 4 additional priorities judged important by the CNTRP leadership (ie, pretransplant organ repair before transplant, improved access to transplant programs and/or transplant waiting list, complications after transplantation, and treatment adherence). The survey questions were pretested, in French and in English, with 15 laypeople, clinicians, and transplant patients. The survey was administered and hosted by the Population Research Laboratory at the University of Alberta (http://www. prl.ualberta.ca/).
Recruitment was primarily done through professional and patient associations that had agreed to distribute and promote the survey invitation to their members. These groups included (i) professional organizations, such as the Canadian Society of Transplantation and the Canadian Blood and Marrow Transplant Group; (ii) health charities, such as the Kidney Foundation of Canada and the Canadian Liver Foundation; (iii) patient advocacy groups, such as the Canadian Transplant Association (CTA); (iv) organ donation organizations, such as Transplant Québec, Trillium Gift of Life and Canadian Blood Services; and (v) members of the CNTRP research network. Facebook and Twitter were also used to invite people to take part in this survey, and the survey was promoted during the launch of the 2016 Transplant Games in Toronto in April 2015. The CTA was used to reach patients and caregivers, since it is the largest national organization that brings together transplant recipients and their family members, transplant candidates, donor families, living donors, and health professionals.
Because the invitations to participate were sent through the various organizations and through social media, it was impossible to accurately estimate the number of invitations sent and to follow up with people who did not answer the survey. Moreover, some participants may have received multiple invitations if they belonged to multiple professional associations. The survey was launched in spring 2015 and was available from April 22 to July 22, 2015. Three followup reminders were sent to Canadian Society of Transplantation, CTA, and CNTRP members.
Based on respondents' survey answers, descriptive statistical analysis was performed to examine the prevalence of the respondents' choices. Pearson χ 2 tests were performed to determine the differences in proportion between each group. For the rankings of priorities, a t test was performed to compare the means of ranking of each research theme between each group. Statistical analysis was performed using R statistical software. 16 A P value less than 0.05 was considered statistically significant.
National Workshop
A facilitated in-person workshop was held in Toronto on November 25 and 26, 2015. To recruit participants, a purposive method (for researchers and HCPs) and a snowball and purposive sample method (for patients and caregivers) were used. 17 To recruit researchers and HCPs, the research team therefore selected individuals who they believed would provide and generate valuable information. For patients, we used a purposive and a snowball strategy that involved inviting patients to suggest other participants. 18, 19 In both cases, we recruited participants from different age groups and regions of Canada, and with different experiences, areas of expertise, and so on.
A total of 75 participants from across Canada were invited, including 36 patients (15 kidney transplant recipients, 6 HCT recipients, 4 waitlisted patients, 4 lung transplant recipients, 3 heart transplant recipients, 3 liver transplant recipients, and 1 multiorgan transplant recipient), 9 caregivers, and 30 researchers and HCPs. Of this total, 46 individuals agreed to participate. Refusals to participate were all due to unavailability at the workshop date. To participate, participants needed to be fluent in English and have experience with and insight into organ and stem cell donation or transplantation. Participants included: (i) patients reflecting a broad range of transplant experiences (waitlisted patients and transplant recipients); (ii) caregivers, including family members of deceased organ donors and transplant recipients, as well as living donors; and (iii) researchers and HCPs involved in organ and stem cell donation or transplantation, including CNTRP researchers involved in various areas of scientific enquiry and with different areas of research expertise (clinical, biomedical, health services, and population health), physicians, surgeons, psychologists, nurses, social workers, dieticians, pharmacists, and physiotherapists. The participants' travel and accommodation expenses were all reimbursed with funding obtained through a CIHR Planning and Dissemination Grant and funds allocated by the CIHR Institute of Infection and Immunity.
The workshop started in the afternoon of November 25 with a series of introductions and background lectures informing participants of the structure and function of the CNTRP, the basics of patient engagement, and the results of both the pilot workshop and national survey. A dinner was organized that evening, and seating was arranged to encourage networking and informal patient and researcher interactions.
On the second day (November 26), participants were divided into 6 small groups of 8 to 9 people. Each group consisted of 2 researchers, 1 HCP, and 4 to 5 patients and/ or caregivers. The first question used to initiate the small group discussions was: "According to your experience, what research priorities should be developed within the CNTRP?" One patient or caregiver was assigned to each group to facilitate these discussions, each of these facilitators having received training before attending the workshop. This training consisted of a 1-hour preworkshop session provided by members of the research team (M.C.F. and V.D.). The facilitators also received a guide detailing the instructions for managing the discussions. The team chose to have patients facilitate the groups to make it easier for patient participants, who might have been too intimidated to contribute or speak openly with a researcher or HCP as a facilitator. To incite and facilitate the discussion, a list of the top 28 research priorities was provided to all participants (SDC, Appendix 2 http:// links.lww.com/TXD/A102). This list included the 10 priorities identified during the pilot workshop and each of the top 3 issues identified for each survey theme (18 priorities in total). Participants were informed that this list was a starting point and were invited to suggest new priorities.
After the small group discussions, the participants came back together for a plenary session, and each group presented its top 3 research priorities identified. Vincent Dumez, a patient and expert in patient partnership and member of the research team, facilitated the plenary. During this session, participants decided to reclassify the research priorities into 2 categories to help facilitate the priority-setting exercise: 1 category for transplantation and 1 for organ/stem cell donation. Afterward, participants voted anonymously on their top 3 priorities for each category, on individual sheets which were collected by the research team. The audio for the small group and plenary discussions were digitally recorded and transcribed for analysis of the discussion. The transcripts were each read by 2 people to ensure that no research priorities were missing from the final list. Transcripts were analyzed using an inductive content and thematic analysis. 18 NVivo version 11 (QSR International) computer software was used for the analysis.
RESULTS

Survey
Demographics and Characteristic of Survey Respondents
In total, 663 unique responses were received. Among the responses received, 505 respondents identified themselves as belonging to 1 or more of the categories indicated (researcher, HCP, patient, caregiver) and were considered for analysis (76.2% completeness rate). The characteristics of the survey respondents are provided in Table 1 . Because the participants could self-identify as more than 1 category (as a researcher and patient or as a caregiver and HCP, for instance), the total number of participants across all categories exceeds 505. Of the participants, 46.3% were patients, 28.7% were caregivers, and 41.6% were researchers/HCPs. Of the researchers and HCPs, 51.7% had conducted clinical research in the field of organ and stem cell donation and transplantation, and 59.0% of patients and caregivers had been participants in clinical research. Table 2 summarizes the 3 most important research priorities identified for each question. For the priorities related to pretransplantation, the 3 groups of respondents were unanimous on the most important priority. In the pretransplant period, the most important priorities were "increasing the number of organs available for transplantation" (51.1% total, 53.2% patients, 54.9% caregivers, 46.7% researchers/ HCPs, P = NS), "the prevention of disease leading to the need for transplantation" (29.6% total, 31.8% patients, 28.9% caregivers and 26.2% researchers/HCPs, P = NS), and "developing new ways to match donors/recipients for improving transplant outcomes" (28.0% total, 25.8% patients, 27.1% caregivers and 29.5% researchers/HCPs, P = NS).
Research Priorities According to the Survey
In the posttransplant period, patients and caregivers were in agreement on research priorities, whereas there were differences between researchers/HCPs and patients and caregivers. The most important priority for the 3 groups of participants was "long-term medical complications of transplantation" (53.7% total, 58.6% patients, 48.6% caregivers, a Because respondents could self-identify in more than 1 category and demographic questions were not mandatory, the totals in each category do not necessarily correspond to their respective denominators. b n (patients) = 230, n (caregivers) = 142, n (researchers and HCPs) = 205. c n (patients) = 230, n (caregivers) = 141, n (researchers and HCPs) = 205. d n (patients) = 231, n (caregivers) = 141, n (researchers and HCPs) = 205. e n (patients) = 221, n (caregivers) = 138, n (researchers and HCPs) = 204. f n (patients) = 229, n (family and caregivers) = 139, n (researchers and HCPs) = 200.
48.6% researchers/HCPs, P < 0.05 patients vs researchers/ HCPs). "Improved graft survival" was more important for researchers/HCPs than for patients and caregivers (39.5% total, 23.9% patients, 34.5% caregivers, 46.2% researchers/ HCPs, P < 0.05 patients vs researchers/HCPs and caregivers vs researchers/HCPs), whereas "how to decrease the number of drugs necessary to prevent rejection" was more important for patients and caregivers than for researchers/HCPs (34.9% total, 38.8% patients, 40.8% caregivers, 27.1% researchers/HCPs, P < 0.05 patients vs researchers/HCPs and caregivers vs researchers/HCPs).
In the biological field, the most important topic was "how to safely decrease or eliminate the need for antirejection drugs" (53.6% total, 61.2% patients, 57.6% caregivers, 45.7% researchers/HCPs). This research priority, however, was ranked significantly higher by patients and caregivers than by HCPs and researchers (P < 0.05 patients vs researchers/HCPs and caregivers vs researchers/HCPs). The second most important priority for patients was "how cancer risk after transplant [can] be minimized" (35.8% total, 42.2% patients, 37.5% caregivers, 29.3% researchers/ HCPs, P < 0.05 patients vs researchers/HCPs). All were in agreement about the third priority, "what biomarkers will indicate or predict the risks of rejection and complications after transplant," (35.6% total, 33.6% patients, 34.0% caregivers and 38.9% researchers/HCPs, P = NS).
There was some disagreement about the most important priority in research related to psychosocial issues. For all participants, the most important priority in psychosocial research was "managing psychological complications (depression and anxiety)" (67.6% total, 60.3% patients, 71.3% caregivers, 69.9% researchers/HCPs), but more caregivers and researchers/HCPs than patients selected this issue (P < 0.05 for patients vs caregivers and patients vs researchers/ HCPs). "Psychological side effects of antirejection drugs" and "exercise and rehabilitation" were chosen as important priorities for 48.2% of participants. However, "psychological side effects of antirejection drugs" was more important for patients and caregivers than for researchers/HCPs (P < 0.001 patients vs researchers/HCPs and caregivers vs researchers/HCPs). In the research on legal and ethical issues, participants identified "presumed consent to donation" as the most important priority (59.2% total, 61.2% patients, 64.8% caregivers, 53.1% researchers/HCPs, P < 0.05 caregivers vs researchers/HCPs). The other top priorities identified were "family veto" (45.2% total, 52.6% patients, 45.8% caregivers and 37.7% researchers/HCPs, P < 0.05 patients vs researchers/HCPs) and "removing financial barriers or disincentives to donation" (42.8% total, 44.8% patients, 45.1% caregivers, and 38.2% researchers/HCPs, P = NS).
In the field of healthcare organization research, the 3 leading priorities were "the implementation of new organ donation programs" (51.9% total, 51.5% patients, 57.7% caregivers and 44.6% researchers/HCPs, P < 0.05 caregivers vs researchers and HCPs), "posttransplant followup" (50.7% total, 53.3% patients, 50.7% caregivers and 46.6% researchers/HCPs, P = NS) and "telemedicine" (40.5% total, 40.6% patients, 43.0% caregivers and 42.6% researchers/HCPs, P = NS).
When asked to rank a list of 14 priorities (1 being most important and 14 being least important), all 3 categories of participants identified "increasing organ donation" as the most important priority. The second priority, "the development of better antirejection drugs," was ranked higher by patients and caregivers than by researchers/HCPs (P < 0.001 patients and caregivers vs researchers/HCPs). Lastly, the third priority, "the induction of tolerance," was ranked higher by patients than by researchers and HCPs (P < 0.05 patients vs researchers/HCPs). Table 3 summarizes the rankings.
NATIONAL WORKSHOP Demographics and Characteristics of Workshop Participants
Forty-six participants from 4 Canadian provinces agreed to participate in the workshop. One patient left before the end of the workshop due to medical problems. Among the remaining 45 participants, 18 (40.0%) were patients, 10 (22.2%) were family members and caregivers, 11 (24.4%) were researchers, and 6 (13.3%) were HCPs. The characteristics of the participants are summarized in Table 4 .
Research Priorities Identified During the Workshop
After the small group and plenary discussions, participants voted on a list of priorities related to both organ/ hematopoietic cell donation and transplantation. A final list was generated using all the research priorities identified in each small group. In the posttransplant period, participants identified the following as the 5 most important research questions: (i) how to improve graft survival, (ii) how to achieve personalized use of antirejection medication through the development of immune monitoring, (iii) how to reduce the adverse effects of antirejection medication and longterm complications, (iv) how to improve psychological support and the management of psychological complications, and (v) how to improve quality of life. Table 5 presents the questions and the votes for each priority, along with excerpts from the discussions.
For organ donation, participants identified the following as the 5 most important research questions: (i) how to educate the public and raise awareness about organ donation, (ii) how to improve donor management and graft quality, (iii) how to foster a culture of donation in hospitals and in society at large, (iv) how to support living donors and families (long-term impact and psychological care), and (v) how to increase the number of deceased and living donors. Table 6 presents the questions and the votes for each priority, along with excerpts from the discussions.
DISCUSSION
The most important research priorities identified through the survey remained consistent with those identified during the workshop. Using the survey, participants ranked increasing organ donation, developing better immunosuppressive drugs (with fewer adverse effects), developing tolerance, 
Research priority rankings
Research theme
Mean a ± SD Mean ± SD Mean ± SD Mean ± SD P P P
(1) Increasing organ donation rates. 3.7 ± 4.0 3.4 ± 3.9 3.3 ± 4.0 4.3 ± 4.1 NS NS NS (2) Better antirejection drugs 4.2 ± 3.6 3.7 ± 3.6 3.6 ± 3.5 5.0 ± 3.6 NS <0.001 <0.001 (3) Tolerance to organ grafts 4.6 ± 3. and improving graft survival as the most important research priorities. During the workshop, participants ranked organ donation focused on increasing the number of organs available and improving the quality of organs and grafts for transplantation as the most important research priorities. With respect to transplantation, the most important priorities were the improvement of graft survival, personalized use of antirejection drugs, and the reduction of adverse effects and long-term complications. Of course, the research priorities identified, such as increasing organ donation, are somewhat vague. It will be up to the research teams and patient research partners to develop research projects that might provide answers to the questions identified. In contrast to the first workshop, the national workshop participants elicited priorities that had not been mentioned or prioritized during either the survey or the pilot workshop, such as the development of strategies to improve communication between medical teams and patients and families, how to address cultural issues in organ donation and transplantation, how to incorporate alternative medicine, and how to make pregnancy safe and possible after transplantation. 2 One possible explanation for this discrepancy could be that the national workshop was attended by researchers and HCPs, who might have involuntarily framed the research priorities in the small group discussions. Indeed, during the pilot workshop, patients and caregivers had time to express themselves freely before researchers and HCPs were included in the discussion.
The results of the survey show that, most of the time, patients and caregivers agree. However, there are some disagreements between patients and researchers/HCPs, and between caregivers and researchers/HCPs. It is unsurprising that patients and caregivers share the same research priorities and that they could disagree with researchers and HCPs given that they do not have the same experience of transplantation and donation. For instance, patients and caregivers prioritized reducing long-term complications after transplantation and decreasing the number of drugs necessary to prevent rejection over improving graft survival. That being said, for 8 of the 18 priorities in the 6 themes, and 6 of 14 priorities to rank, there were no significant differences between the 3 groups of participants.
Previous studies have described priority-setting exercises in the field of SOT 8, 9, 13, 20, 21 ; however, this is the first study to present a research priority-setting study that combines the fields of donation, SOT and HCT (patients, caregivers, researchers, and HCPs). Bringing these 3 communities together for this exercise reflected the scope and mandate of the CNTRP, the only national program in the world that unites these 3 clinical research areas together with patients. 15 Combining these patients in this research prioritysetting study also makes sense from a disease management perspective, because HCT and SOT patients share some similarities, such as life-threatening conditions, immunosuppressive drugs, psychosocial challenges, rejection (or graft-versus-host disease), and infectious, cardiovascular, and neoplastic complications.
Tong and colleagues 13 recently conducted a systematic review of 28 priority-setting exercises in SOT. Only 9 of these studies included patients. Research priorities identified in that review were related to organ donation, waitlisting and allocation, histocompatibility and immunology, immunosuppression, complications (graft-and recipient-related), reproduction, psychosocial and lifestyle issues, and disparities in access and outcomes. 13 These priorities bear some similarities to those identified during this priority-setting exercise.
Recently, a British team reported the results of a patient partnership priority-setting exercise in kidney transplantation. 21 That team used a survey with open-ended questions, with 183 survey respondents, and a consensus workshop to identify the top 10 priorities in kidney transplantation. The 3 most important research priorities identified during the survey were: (i) the best treatment for improving graft survival, (ii) the development of reliable tools to assess the suitability of organs for transplantation and predict outcomes, and (iii) the development of treatment for vascular rejection. During the workshop, participants identified the top 10 research priorities, all of which were biomedical, including the treatment of vascular rejection, the tailoring of immunosuppression for an individual patient, the prevention of sensitization after the failure of a first transplantation, the development of tolerance and the best combination of immunosuppressive drugs. Psychological complications and organ donation were not mentioned as research priorities in this study. 21 The research priorities identified during the survey and the national workshop are similar to the unmet clinical needs in transplantation identified by Stegall et al, 22 namely, those surrounding improving long-term graft survival, increasing the number of organ donors, immunosuppressive drugs with fewer adverse effects, induction of specific immunologic unresponsiveness, prevention and treatment of long-term medical complications (viral and cancer), and rehabilitation.
Recently, the National Health Institute has convened working groups to determine the research needs for HCT patients. No priority-setting exercises involving patients and caregivers have been reported in the field of HCT. One of the working groups conducted a scoping review to look at the research needs related to patient-reported outcomes and health-related quality of life. The priority domains of research are sexual dysfunction, fatigue, sleep disruption, nonadherence, health behaviors, and psychological dysfunction. 23 Other working groups published reviews presenting the current knowledge and unmet needs in the field of HCT for inherited bone marrow failure syndromes, 24 for severe combined immunodeficiency syndromes, and for sickle cell disease and thalassemia. 25 Improving long-term survival and morbidity, alternative donor sources, the conditioning of HCT, and chronic graft-versus-host disease were reported as unmet needs in research. 24, 25 There are some similarities with the research priorities elicited during the survey and the workshop.
One strength of our priority-setting exercise was the number of survey respondents, with 505 participants completing the survey, of which 46% identified themselves as patients. Furthermore, patients and caregivers-SOT and HCT patients, transplant candidates, living organ donors and family members of deceased donors-with an extensive and diverse range of personal experiences with transplantation and donation were included in the national workshop. That being said, this project also had its limitations. The research team recognizes that the survey questions were geared toward SOT and may have lacked relevance to HCT recipients. This could be explained by the fact that there was no one representing the HCT community on the research team during the survey's creation. In addition, patients from ethnic minorities were underrepresented in the national workshop (vis-à-vis the national demographics, considering that 19.1% of the Canadian population identifies as a visible minority), 26 although 1 patient from the Aboriginal community did participate. There is therefore a need to validate the research priorities with Canada's different ethnic groups, including Aboriginals, particularly because there are disparities in access to kidney transplantation among Aboriginals and patients from ethnic minorities. 27 
CONCLUSIONS
This is the first national research priority-setting exercise in donation, SOT, and HCT in Canada. The priorities identified are the result of discussions with patients, family members, caregivers, HCPs, and researchers, and they will inform the identification, prioritization and funding of projects, and the future strategic directions of the CNTRP. This priority-setting exercise enabled a dialogue between patients, researchers, and HCPs within the CNTRP, as well as the development of the CNTRP patient-partnership strategy. In the coming years, the research team will assess how this exercise has shaped research projects within the CNTRP. The priorities identified will continue to be reassessed in the future to ensure that they are still relevant and have not become obsolete and to determine whether new priorities have emerged.
